000 | 01166 a2200313 4500 | ||
---|---|---|---|
005 | 20250512211207.0 | ||
264 | 0 | _c19831217 | |
008 | 198312s 0 0 eng d | ||
022 | _a0022-4790 | ||
024 | 7 |
_a10.1002/jso.2930240208 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMetzger, U F | |
245 | 0 | 0 |
_aCombined modality treatment of pancreatic cancer: implications for the surgeon. _h[electronic resource] |
260 |
_bJournal of surgical oncology _cOct 1983 |
||
300 |
_a107-12 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRadiotherapy Dosage |
700 | 1 | _aKisner, D L | |
700 | 1 | _aGhosh, B C | |
773 | 0 |
_tJournal of surgical oncology _gvol. 24 _gno. 2 _gp. 107-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jso.2930240208 _zAvailable from publisher's website |
999 |
_c6355580 _d6355580 |